Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
11,448,903
-
Share change
-
+632,709
-
Total reported value
-
$89,297,484
-
Price per share
-
$7.80
-
Number of holders
-
51
-
Value change
-
+$3,844,548
-
Number of buys
-
26
-
Number of sells
-
18
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2017
As of 31 Mar 2017,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,448,903 shares.
The largest 10 holders included
FMR LLC, INTERWEST VENTURE MANAGEMENT CO, FRAZIER MANAGEMENT LLC, BB BIOTECH AG, Aisling Capital LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., Broadfin Capital, LLC, Omega Fund Management, LLC, and VANGUARD GROUP INC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.